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Introduction. A possible therapeutic effect of diagnostic tubal patency testing has been 
debated in the literature for half a century. Further debate surrounds whether oil-soluble or 
water-soluble contrast media might have the bigger fertility-enhancing effect. Historically a 
variety of agents have been used to “flush” the fallopian tubes, although tubal flushing does not 
currently form part of routine practice in the treatment of fertility delay.
Target of the study.To evaluate the effect of flushing a woman's fallopian tubes with oil- or 
water-soluble contrast media on subsequent pregnancy outcomes in couples with infertility. 
Materials and methods. Eight randomised controlled trials were identified and included in 
this review. A further one randomised controlled trial is ongoing. All trials were assessed for 
quality criteria. The studied outcomes were pregnancy, live birth (and ongoing pregnancy), 
miscarriage, ectopic pregnancy, treatment complications including pain, intravasation of 
contrast medium, infection and haemorrhage, and image quality.
Results. Tubal flushing with oil-soluble media versus no intervention was associated with a 
significant increase in the odds of pregnancy (OR 3.57, 95%CI 1.76-7.23). There were no data 
from RCTs to assess tubal flushing with water-soluble media versus no intervention. Tubal 
flushing with oil-soluble media was associated with a significant increase in the odds of live 
birth versus tubal flushing with water-soluble media (OR 1.49, 95%CI 1.05-2.11) but the odds 
of pregnancy showed no significant difference (OR 1.23, 95%CI 0.95-1.60) and there was 
evidence of statistical heterogeneity for these two outcomes. The addition of oil-soluble media 
to flushing with water-soluble media (water-soluble plus oil-soluble media versus water- 
soluble media alone) showed no significant difference in the odds of pregnancy (OR 1.16, 
95%CI 0.78-1.70) or live birth (OR 1.06, 95%CI 0.64-1.77).
Conclusions. There is some evidence of effectiveness of tubal flushing with oil-soluble 
contrast media in increasing the odds of pregnancy versus no intervention. The limited 
evidence of an increase in the odds of live birth from tubal flushing with oil-soluble contrast 
media versus water-soluble contrast media must be interpreted cautiously. Further robust 
randomised trials, comparing oil-soluble versus water-soluble media and comparing each 
versus no intervention, are required to provide convincing evidence as to whether the technique 
should be accepted into widespread clinical practice.
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Introduction: To investigate levels o f antiovarian autoantibodies in girls and young women 
with disturbances of menstrual cycle before and during treatment with hormonal therapy. 
Menopause usually occurs approximately at the age of 50. Premature ovarian failure (POF) is a 
disorder defined as a pathologic termination o f menstrual cycle after puberty and before the age 
of 40. Frequency of this disorder is approximately 1%. Hormonal levels show 
hypergonadotrophic hypoestrism (FSH more than 40 IU/l). The onset o f the disease may be 
very slow. Menarche and regular menstrual cycles may be followed by menstrual cycle 
disorders -  oligomenorrhoea or secondary amenorrhoea. Sterility or infertility at the 
reproductive age could be manifestations of the early stage of the disease. One of the possible 
causes o f premature ovarian failure could be an autoimmune process beginning at any time 
during the reproductive period. Autoimmune damage of the ovarian hormonal production 
places this disease between the autoimmune endocrinopathies, characterized by direct 
destruction of the target cells, such as thyroiditis, insulin dependent diabetes and Addison’s 
disease.
Material and methods: Studied group included 39 patients. 18 patients were treated for 
primary amenorrhoea, 21 for menstrual cycle disorders. Patients included in the study were 
repeatedly examined at the beginning of the study and after six months during which they were 
treated by estrogen and gestagen. In all patients we have tested FSH, LH and FSH/LH ratio, 
presence of antiovarian antibodies. Results were compared with those obtained in control
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women. 21 antiovarian antibodies positive patients were indicated for laparoscopic biopsy. 
Biopticsample was examined using light and electron microscopy.
Results: Our treatment with hormonal therapy lead to the reduction of ovarian antigens. In 
85% of the cases marked decrease of antiovarian autoantibodies levels was observed, while in 
28% of the cases the levels were undetectable. From morphological changes of the bioptic 
sample enhanced atresia of follicules at different developmental stages was frequently 
observed. It evoked marked reduction of follicular apparatus up to its complete disappearing. 
Conclusion: The results of our study and mapping of the antiovarian antibodies positivity 
support our hypothesis that the antiovarian antibodies positivity corresponds with the clinical 
symptoms. Appropriate treatment with hormonal replacement therapy minimizes ovarian 
destruction, preserves ovarian hormonal functions and saves healthy ovarian tissue necessary 
for future fertility.
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Вступ. Народження недоношеної дитини пов'язане з певним ризиком постнатальної 
затримки фізичного розвитку (ФР).
Мета. Дослідити динаміку показників ФР недоношених дітей залежно від маси тіла з 
моменту народження, і вплив грудного вигодовування на швидкість ФР протягом 1-го 
року.
Матеріали і методи дослідження. Використовувалися центильні таблиці для 
недоношених від 22 до 50 тижнів (Fetal-infant Growth Chart for preterm 
infants,WHO,2006), антропометричний калькулятор ВООЗ Anthro з обчисленням 
сигмальних відхилень (Z- scores).Bd діти були розділені на 3 групи залежно від маси 
тіла при народженні (1-а- 2499-1500г, 2-а - 1499 -1000г, 3-я - <999г).
Висновки. Частота затримки ФР серед дітей у віці 6 місяців була 26,87%, (95% ДІ 17,72­
38,52%) в 1-й групі; 77,78%(95% ДІ 63,73-87,46%) у 2-й групі; 100% у 3-й групі. Частота 
затримки ФР серед дітей у віці 1 року була 7,46% (95% ДІ 3,23-16,31%), 33,3з%(95% ДІ 
21,3б-47,93%), 63,16 % (95% ДІ 4 1 , о 4 - 8 0 ,8 5 % )  відповідно. Затримка маси відносно 
довжини тіла помічена серед дітей у віці 6 місяців: 5,97%(95% ДІ 2,35-14,37%) в 1-й 
групі, 33,33% (95% ДІ 21,36-47,93%) у 2-й групі, 47,37% (95% ДІ 27,33-68,29%) в 3-й 
групі. Серед дітей у віці 1 року 2,99% (95% ДІ 0,82-10,25%) 1-ї групи, 8,89% (95% ДІ 
3,51-20,73%) 2-ї групи, 15,79% (95% ДІ 5,52-37,57%) 3-ї групи також відмітим дефіцит 
маси відносно довжини тіла. У дітей 2-ї та 3-ї груп у віці 6-ти місяців достовірно частіше 
зустрічається недостатня та надмірно недостатня вага. В 1 рік відмічено позитивну 
динаміку в усіх групах, але в групах дітей 2-ї та 3-ї зберігається високий відсоток дітей з 
затримкою ФР. Грудне вигодовування - найбільш фізіологічний метод догляду за 
недоношеними дітьми.
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